PCI provides clients with integrated end-to-end drug development, manufacturing, advanced drug delivery & drug-device combination services and packaging capabilities across the product lifecycle.
We offer expert clinical to commercial capabilities including sterile fill- finish, lyophilization, drug-device combination assembly, processing of highly potent drug products, oral solid and liquid dosage forms, clinical trial services and enhanced commercialization solutions.
It is this integrated offering that has the potential to increase a products’ speed to market and commercial success for our clients. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of CDMO services.